Baijin Life Science Holdings Limited (1466.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 468.68M |
| Enterprise Value | 520.84M |
| P/E Ratio | 98.2 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 7.04 |
| Price/Book Ratio | 7.01 |
| Enterprise/Revenue | 7.27 |
| Enterprise/EBITDA | -341.55 |
Fiscal Year
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | -0 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.06 |
Income Statement
| Revenue | 135.56M |
| Revenue/Share | 0.13 |
| Gross Profit | 41.99M |
| EBITDA | 6.26M |
| Net Income | -316,000 |
| Diluted EPS | -0 |
Balance Sheet
| Total Cash | 57.46M |
| Total Cash/Share | 0.06 |
| Total Debt | 85.43M |
| Total Debt/Equity | 0.61 |
| Current Ratio | 4.21 |
| Book Value Per Share | 0.17 |
Price History
| 52-Week Change | 57.97 |
| 52-Week High | 1.11 |
| 52-Week Low | 0.47 |
| Moving Average 50 Days | 0.55 |
| Moving Average 200 Days | 0.55 |
Statistics
| Average Volume | 954,466 |
| Shares Outstanding | 773.37M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 61:58 |
| Last Split Date | April 06, 2022 |
AD
